Idiopathic inflammatory myopathies

IE Lundberg, M Fujimoto, J Vencovsky… - Nature Reviews …, 2021 - nature.com
Idiopathic inflammatory myopathies (IIM), also known as myositis, are a heterogeneous
group of autoimmune disorders with varying clinical manifestations, treatment responses …

[HTML][HTML] Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies

MG Danieli, E Antonelli, MA Piga, MF Cozzi… - Autoimmunity …, 2023 - Elsevier
We investigated the relationship between oxidative stress and inflammatory myopathies. We
searched in the current literature the role of mitochondria and respiratory chain defects as …

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

MG Hanna, UA Badrising, O Benveniste… - The Lancet …, 2019 - thelancet.com
Background Inclusion body myositis is an idiopathic inflammatory myopathy and the most
common myopathy affecting people older than 50 years. To date, there are no effective drug …

Survival and associated comorbidities in inclusion body myositis

E Naddaf, S Shelly, J Mandrekar… - …, 2022 - academic.oup.com
Objective To evaluate survival and associated comorbidities in inclusion body myositis (IBM)
in a population-based, case-control study. Methods We utilized the expanded Rochester …

[HTML][HTML] Exploring challenges in the management and treatment of inclusion body myositis

MP Skolka, E Naddaf - Current opinion in rheumatology, 2023 - journals.lww.com
Addressing the obstacles encountered by patients with IBM and the medical community
presents a multitude of challenges. Effectively surmounting these hurdles requires …

[HTML][HTML] Amplifying the heat shock response ameliorates ALS and FTD pathology in mouse and human models

M Ahmed, C Spicer, J Harley, JP Taylor, M Hanna… - Molecular …, 2023 - Springer
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are now known as
parts of a disease spectrum with common pathological features and genetic causes …

[HTML][HTML] Imaging biomarkers in the idiopathic inflammatory myopathies

AS Zubair, S Salam, MM Dimachkie… - Frontiers in …, 2023 - frontiersin.org
Idiopathic inflammatory myopathies (IIMs) are a group of acquired muscle diseases with
muscle inflammation, weakness, and other extra-muscular manifestations. IIMs can …

[HTML][HTML] Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial

PM Machado, MP McDermott, T Blaettler… - The Lancet …, 2023 - thelancet.com
Background Inclusion body myositis is the most common progressive muscle wasting
disease in people older than 50 years, with no effective drug treatment. Arimoclomol is an …

[HTML][HTML] Cytotoxic immune cells do not affect TDP-43 and p62 sarcoplasmic aggregation but influence TDP-43 localisation

B McCord, RM Day - Scientific Reports, 2023 - nature.com
Sporadic inclusion body myositis (sIBM) is an idiopathic inflammatory myopathy with
invasion of CD8 T cells in muscle and aggregation of proteins in the sarcoplasm. TDP-43 …

[HTML][HTML] Novel Variants in the VCP Gene Causing Multisystem Proteinopathy 1

RCA Columbres, Y Chin, S Pratti, C Quinn… - Genes, 2023 - mdpi.com
Valosin-containing protein (VCP) gene mutations have been associated with a rare
autosomal dominant, adult-onset progressive disease known as multisystem proteinopathy …